Register for OBR daily




To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

KERX $5.96 0.5200 +9.56%
NLNK $17.62 1.4050 +8.67%
LOXO $24.98 1.9300 +8.37%
MNKD $1.45 0.1000 +7.41%
CORT $5.05 0.2800 +5.87%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

CBMG $15.54 -1.7300 -10.02%
PVCT $0.44 -0.0489 -9.98%
BDSI $3.11 -0.2700 -7.99%
VRML $1.30 -0.0900 -6.47%
CERU $3.10 -0.1800 -5.49%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 888 | 889 | 890 | 891 | 892 | 893 | 894 | 895 | 896 | 897 | Next > | Last >>

Bigger Role Seen for Breast Cancer Drug

(New York Times) Dec 5, 2012 - The widely prescribed drug tamoxifen already plays a major role in reducing the risk of death from breast cancer. But a new study suggests that women should be taking the drug for twice as long as is now customary, a finding that could upend the standard that has been in place for about 15 years.
read article 



Pfizer Breast Cancer Drug Delays Progression 18 Months

(Reuters) Dec 5, 2012 - An experimental drug showed impressive effectiveness and safety in a mid-stage trial against a common form of advanced breast cancer, lifting Pfizer Inc shares nearly 2 percent.
read article 



Roche, Pfizer, Sanofi Plan $72.7 Million Stem-Cell Bank

(Bloomberg) Dec 5, 2012 - Drug companies and universities are spending 55.6 million euros ($72.7 million) to develop a bank of stem cells to use in testing potential treatments for hard-to- treat diseases.
read article 



Study Raises Questions on Coating of Aspirin

(New York Times) Dec 4, 2012 - While aspirin may prevent heart attacks and strokes, a commonly used coating to protect the stomach may obscure the benefits, leading doctors to prescribe more expensive prescription drugs, according to a study published Tuesday in the journal Circulation.
read article 



Young Docs Don't Want To Be Internists Despite Better Pay And Obamacare's Promise

(Forbes) Dec 4, 2012 - Despite improving pay and the critical role primary care physicians will play in the future of health care in the U.S., there remains less interest by doctors-in-training in general medicine than specialty disciplines.
read article 



Review & Outlook: The FDA vs. Free Speech

(Wall Street Journal) Dec 4, 2012 - A court decision guts the agency crackdown on off-label drug promotion.
read article (paid subscription required) 



Surgical Milestone Reached for Urologic Oncology Chief at The Cancer Institute of New Jersey

(CINJ) Dec 4, 2012 - Marking a major milestone in what has become a fast-growing standard of care in prostate cancer surgery, the chief of urologic oncology at The Cancer Institute of New Jersey has completed his 1,000th robotic prostatectomy at Robert Wood Johnson University Hospital (RWJUH), the Flagship Hospital of The Cancer Institute of New Jersey.
read press release 



NCCN Biomarkers Compendium Now Available

(Yahoo! Finance) Dec 5, 2012 - The National Comprehensive Cancer Network® (NCCN®) today announces the availability of the NCCN Biomarkers Compendium™, a tool developed to identify how biomarkers are appropriately used to screen, diagnose, monitor, and provide predictive or prognostic information to ensure, ultimately, that patients with cancer have access to appropriate testing.
read article 



The Leukemia & Lymphoma Society Seeks to Fund Research in Six Critical Areas of Unmet Medical Need

(LLS) Dec 4, 2012 - The Leukemia & Lymphoma Society (LLS) has issued new requests for proposals from researchers in six critical areas of unmet medical need.
read press release 



54th ASH Annual Meeting to Celebrate Latest in Hematology Research, Education, Patient Care

(ASH) Dec 4, 2012 - The American Society of Hematology (ASH) will host approximately 20,000 attendees from around the world at its 54th annual meeting and exposition, the preeminent medical meeting for physicians and scientists in hematology, December 8-11, at the Georgia World Congress Center in Atlanta.
read press release 



Conquer Cancer Foundation Funds Some of the Top Cancer Advances of the Year

(Conquer Cancer Foundation/ASCO) Dec 3, 2012 - Three studies featured in the recently released “Clinical Cancer Advances 2012: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology,” which identifies the top advances of the year in clinical cancer research, were funded in part by Conquer Cancer Foundation of ASCO Career Development Awards (CDAs).
read press release 



Peregrine Shows Desperation in Dusting Off Ancient Brain Tumor Drug

(TheStreet) Dec 5, 2012 - Peregrine Pharmaceuticals is either desperate or stupid if blowing dust off the ancient Cotara brain tumor program is the company's next great idea.
read article 



Strides Arcolab Inks Pact with Eli Lilly for Cancer Drugs

(Economic Times) Dec 5, 2012 - US-based drug firm Eli Lilly and Co and domestic firm Strides Arcolab today said they have entered into a pact to expand marketing of generic cancer medicines in the emerging markets.
read article 



Ondansetron (Zofran) 32 mg, Single Intravenous (IV) Dose: Updated Safety Communication – Product Removal due to Potential For Serious Cardiac Risks

(FDA) Dec 4, 2012 - ISSUE: FDA is notifying health care professionals that the 32 mg, single intravenous (IV) dose of the anti-nausea drug Zofran (ondansetron hydrochloride) will no longer be marketed because of the potential for serious cardiac risks.
read article 



Breath Test May Detect Colon Cancer

(WebMD) Dec 5, 2012 - A breath test similar to the one used to determine when a driver has had too much to drink shows promise as a screening tool for cancer.
read article 



After Parent's Cancer Death, One in Five Kids Self-Injure

(Reuters Health) Dec 4, 2012 - One in five teens who lost one of their parents to cancer cut or burn themselves, compared to one in ten teens with two living parents, according to a new Swedish study.
read article 



Fewer Poor Cancer Patients Referred for Drug Trials

(Reuters) Dec 4, 2012 - Among people with advanced cancer, poorer patients are less likely to be referred for clinical trials of experimental drugs, a new study from the UK suggests.
read article 



Black Women Less Likely to Receive Improved Surgical Procedure for Breast Cancer

(AACR) Dec 5, 2012 - Black women with breast cancer were 12 percent less likely than white women with the disease to receive a more minimally invasive procedure — sentinel lymph node biopsy — for staging of breast cancer, according to data tracking the treatment of patients through 2007.
read press release 



Less Invasive Surgery Detects Residual Breast Cancer in Lymph Nodes after Chemotherapy

(Mayo Clinic) Dec 5, 2012 - A study conducted through the American College of Surgeons Oncology Group and led by Judy Boughey, M.D. a breast surgeon at Mayo Clinic shows that a less invasive procedure known as sentinel lymph node surgery successfully identified whether cancer remained in lymph nodes in 91 percent of patients with node-positive breast cancer who received chemotherapy before their surgery.
read press release 



Higher Doses of Fulvestrant Prolonged Survival in Patients With Advanced Breast Cancer

(SABCS) Dec 5, 2012 - Increasing the dose of fulvestrant from 250 mg to 500 mg improved median overall survival in women with locally advanced or metastatic estrogen receptor-positive breast cancer, according to updated data from the CONFIRM trial presented at the 2012 CTRC-AACR San Antonio Breast Cancer Symposium, held here Dec. 4-8.
read press release 



Pfizer Experimental Drug Slows Late-Stage Breast Cancer

(BloombergBusinessweek) Dec 5, 2012 - Pfizer Inc.’s experimental breast cancer drug stopped progression of an incurable form of the disease for more than two years in a study, a dramatic delay for those with the second-deadliest cancer in women.
read article 



Drug Shows Promise in Prostate Cancer Spread to Bone

(U-M CCC) Dec 4, 2012 - A new drug demonstrated dramatic and rapid effects on prostate cancer that had spread to the bone, according to a study reported by University of Michigan Comprehensive Cancer Center researchers.
read press release 



Extended Use of Breast Cancer Drug Suggested

(New York Times) Dec 5, 2012 - A study says that the breast cancer drug tamoxifen should be taken for 10 years rather than for the customary five years to help reduce the risk of death.
read article 



For Second Opinion, Consult a Computer?

(New York Times) Dec 3, 2012 - I.B.M.’s Watson for Healthcare has yet to focus directly on diagnosis. The company is working with Memorial Sloan-Kettering Cancer Center to teach Watson to interpret clinical information and, eventually, help determine treatment.
read article 



Sucampo Drops After FDA Delays Amitiza Decision

(Bloomberg) Dec 3, 2012 - Sucampo Pharmaceuticals Inc. fell the most in five months after U.S. regulators delayed a decision on expanding the use of its Amitiza drug to treat opioid-induced constipation in patients with chronic, non-cancer pain.
read article